London startup to trial drug to prevent cancer therapy side-effect ‘cytokine storm’
The Guardian Business ·
A London-based startup is about to trial a drug at six NHS hospitals that could stop people on cancer immunotherapy getting a life-threatening side-effect. …
A London-based startup is about to trial a drug at six NHS hospitals that could stop people on cancer immunotherapy getting a life-threatening side-effect. Poolbeg Pharma said its oral drug POLB 001 could make treatment for blood cancer safer by preventing cytokine release syndrome (CRS) , when the immune system goes into overdrive and attacks the body, leading to organ damage. …
Original source: The Guardian Business